CVE-2024-21876
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability via a URL parameter in Enphase IQ Gateway (formerly known as Envoy) allows an unautheticated attacker to access or create arbitratry files.This issue affects…
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.80%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability via a URL parameter in Enphase IQ Gateway (formerly known as Envoy) allows an unautheticated attacker to access or create arbitratry files.This issue affects Envoy: from 4.x to 8.x and < 8.2.4225.
- CVSS 4.0
- 9.3 CRITICALCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
- EPSS
- 0.80% probability · 54th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-22
- Affected
- enphase/iq gateway firmware
- Source
- csirt@divd.nl
References
- https://csirt.divd.nl/CVE-2024-21876Third Party Advisory
- https://csirt.divd.nl/DIVD-2024-00011Third Party Advisory
- https://enphase.com/cybersecurity/advisories/ensa-2024-1Vendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.